Instrument NameDexcom IncInstrument Symbol(DXCM-Q)

Instrument ExchangeNASDAQ

This medical device company is down but not out.

Investors likely felt that with a compelling new product on the market, the company should have posted more meaningful growth.

The S&P 500 Index ($SPX ) (SPY ) Friday closed down by -0.03%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.61%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +0.59%. Stocks on Friday settled mixed, with the Dow Jones Industrials falling...

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.86%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.38%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +1.53%. Stocks today are moderately higher, with the Nasdaq 100 posting a...

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.54%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.38%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.84%. Stocks today are moderately higher, with the Nasdaq 100 posting a...

DXCM earnings call for the period ending September 30, 2024.

Recent developments might have scared away some investors, but patience could pay off.

A discounted stock can present an opportunity when there's a quality business behind it.

Is DexCom's business in trouble, or could this be a great buying opportunity for investors?

Their headwinds won't last forever.

The company's game-changing technology could improve the lives of hundreds of millions of patients.

Demand for blood glucose monitors is strong, but DexCom isn't the only competitor in this lucrative market.

Sometimes, a discounted stock can present a valuable opportunity.

NEW YORK, NY - (NewMediaWire) - September 29, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM) securities between January 8, 2024 and July 25,...

Two key uncertainties make the prospect of buying it today riskier than is desirable.

It isn't the most likely candidate to make someone a millionaire, but it's theoretically possible.

These once-sizable artificial intelligence (AI) holdings for Google parent Alphabet have been paired down big-time over the last two quarters.

No need to break the bank to get in on these excellent companies.

The stock isn't normally this cheap, and investors should take advantage.

The stock has delivered superior returns in the past 19 years.

These stocks took a dive recently, and that could spell opportunity.

September S&P 500 E-Mini futures (ESU24) are trending up +0.17% this morning as market participants awaited an annual review of U.S. jobs data as well as the Federal Reserve’s July meeting minutes for further clues on the path of interest rates.

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.20%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.15%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.24%. US stocks Tuesday gave up an early advance and posted modest losses. Weakness in...

The S&P 500 Index ($SPX ) (SPY ) today is down -0.18%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.32%. US stocks today gave up an early advance and turned lower. Weakness in chip...

These companies' growth paths should only be briefly interrupted by headwinds.